Home / About Us / Board of Directors

Board of Directors

Meet the Board

Board of Directors Board of Governors Emeritus Members

Meet the Biocom California Board of Directors, working to ensure Biocom California’s programs, initiatives, and strategies work to accelerate life science across California.

board-of-directors

Board of Directors

Sabrina Martucci Johnson

Chair; President and CEO,

Daré Biosciences

Carin Canale-Theakston

Vice Chair, Professional Services; Executive Biotech Advisor,

Inizio and Inizio Evoke.

Ranjeet Banerjee

Vice Chair, DE&I; CEO

Cold Chain Technologies

Aliza Apple, Ph.D.

Vice President, Catalyze360 AI/ML,

Eli Lilly

Matthew Bresnahan, J.D.

Partner,

Wilson Sonsini

Dan Burgess

Chairman,

Nabriva Therapeutics, PLC

Amy Butler, Ph.D.

President, Biosciences,

Thermo Fisher Scientific

Chuck Dadswell, J.D.

Sr. VP & General Counsel,

Illumina

Stephen Ferruolo, J.D., Ph.D.

Secretary; Dean,

USD School of Law

Joydeep Ganguly

Sr. Vice President, Corporate Operations & Chief Sustainability Officer

Gilead Sciences

Jennifer Giottonini Cayer

Chief Business Officer, Pulmocide; Board Member, Biocom California; Board Member

UCSD Moore’s Cancer Center

Enoch Kariuki, PharmD

Board Director,

Zentalis Pharmaceuticals and Imago Biosciences

Dan Kleeburg

Treasurer; Partner,

Ernst & Young LLP

Susan Krumplitsch

Partner,

DLA Piper

Paul Mola

Carolyn Ng, Ph.D.

Business Unit Partner,

TPG Life Sciences Innovations

Steve Pacelli

EVP & Managing Director

Dexcom Ventures

Bernard Parker

Chief Business Officer,

SPHBio

Ken Rollins

Partner,

Cooley

Christophe Schilling, Ph.D.

CEO,

Genomatica, Inc.

Tim Scott

President and CEO

Biocom California

Larry Stambaugh

Chairman,

Molecular Assemblies, Inc.

Nick Tait

Principal,

Marsh & McLennan Agency

Nancy Whiting, Pharm.D.

President and CEO,

Recludix Pharma

“It’s so rewarding to see the tremendous impact the board has on advancing Biocom California’s key initiatives and, through that, invigorating the entire Southern California life science community.”

Carin Canale

CEO, Canale Communications

“As past Chairman and current Board member of Biocom California, I am thrilled that this organization continues to have such an impactful role in building the Life Science industry in California and in doing so contributes in a big way to the innovation economy. On a personal note, I treasure the time I spend on this dedicated Board with so many passionate and innovative leaders of this great industry.”

Magda Marquet

Co-Chairman & Founder, Althea

board-of-governors

Board of Governors

Matt Abernethy

CFO,

Neurocrine Biosciences

Connor Bates

Vice President/General Manager, Infusion Medication Management,

BD

Neil Bence, Ph.D.

VP, Head of Oncology Discovery,

Bristol Myers Squibb

Michael Boss

Sr. Vice President,

Alexandria Real Estate Equities

Rick Bregman

San Diego Market President and National Co-Head,

Bank of America’s Healthcare Banking Group

Thomas Briggs

Partner,

Jones Day

Mark Cafferty

President & CEO,

SD Regional Economic Development Corp.

Deanne Calvert, J.D.

Vice President, State Government Affairs,

Sanofi Genzyme, US

Sunita Cooke, Ph.D.

Superintendent/President,

Mira Costa College

David Crean, Ph.D.

Managing General Partner,

Coast Bioventures LLC

Bassil Dahiyat, Ph.D.

President and CEO,

Xencor

DeeDee DeMan

Founder, Chairman & CEO,

Bench International

Thierry Diagana, Ph.D.

Head of Global Health & California Sites Head

Novartis Biomedical Research

Emad Fareed

Partner,

KPMG, Inc

Michael Farrington

Oliver Fetzer, Ph.D.

CEO,

Viridos

Gregory Frost, Ph.D.

Chairman & CEO,

EXUMA Biotech

Jeffrey Guise Ph.D. Esq.

Partner,

Eversheds Sutherland

Ronnie Hanecak, Ph.D.

Senior Director, Licensing,

UCI Beall Applied Innovation

Stephen Hatke

Vice President of Operations & Thousand Oaks Site Head

Takeda

Jeffrey Hessekiel

Executive Vice President & General Counsel,

Exelixis, Inc.

Richard Heyman, Ph.D.

Venture Partner

ARCH Ventures

Ted Jacobs

Vice Chairman,

CBRE

Cheston Larson, J.D.

Partner & Co-Chair, Life Sciences Industry Group,

Latham & Watkins LLP

Kathryn Lowell

Group Vice President, Global Government Affairs

BioMarin Pharmaceutical Inc.

James Mackay, Ph.D.

CEO,

Aristea Therapeutics

Hala Madanat, Ph.D.

Vice President for Research & Innovation,

SDSU

Trevor Martin, Ph.D.

Co-Founder & CEO,

Mammoth Biosciences

Damien McDevitt, Ph.D.

CEO,

Aspen Neuroscience

Juli Moran

San Diego Office Managing Partner & Managing Director,

Deloitte Consulting LLP

Marc Morley, J.D.

Member,

Mintz, Levin, Cohn, Ferris, Glovsky and Popeo

Corinne Peek-Asa, Ph.D.

Vice Chancellor, Research,

UCSD

Bob Ramos, J.D.

Partner,

Procopio

Tina Self

Senior VP/Biologics Manufacturing Capability Cluster Leader & Berkeley Site Head

Bayer

Tsuneo Takahashi

President,

NF Corporation

Olivier Toury

Co-Founder & CEO,

Neuroservices-Alliance

Kevin Tremblay

Sr. Director, SD Market Leader,

Biomed Realty

David Webb, Ph.D.

CEO,

Rev-Therapeutics

emeritus-members

Emeritus Members

John Dunn

General Counsel, Vital Therapies

Wain Fishburn

Chair,

Critical Path Institute

Lisa Haile

Partner & Global Life Science Sector Chair,

DLA Piper

David Hale

Chairman,

Hale BioPharma Ventures

Guy Iannuzzi

CEO,

Mentus

Paul Laikind, Ph.D.

Principal,

GVM BioBusiness

Jack Lief

Director,

CeleCor

Magda Marquet, Ph.D.

Co-Founder & Co-CEO,

ALMA Life Sciences, LLC

Joe Panetta

President Emeritus

Biocom California

Trindl Reeves

Chief Sales Officer,

Marsh & McLennan Agency